Does ROSUVASTATIN\ROSUVASTATIN Cause Interstitial lung disease? 7 Reports in FDA Database
Lower Your Cholesterol — The Natural Way
The Oxidized Cholesterol Strategy: a science-backed plan for heart health.
According to the FDA Adverse Event Reporting System (FAERS), 7 reports of Interstitial lung disease have been filed in association with ROSUVASTATIN\ROSUVASTATIN. This represents 1.3% of all adverse event reports for ROSUVASTATIN\ROSUVASTATIN.
7
Reports of Interstitial lung disease with ROSUVASTATIN\ROSUVASTATIN
1.3%
of all ROSUVASTATIN\ROSUVASTATIN reports
0
Deaths
7
Hospitalizations
How Dangerous Is Interstitial lung disease From ROSUVASTATIN\ROSUVASTATIN?
Of the 7 reports, 7 (100.0%) required hospitalization.
Is Interstitial lung disease Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for ROSUVASTATIN\ROSUVASTATIN. However, 7 reports have been filed with the FAERS database.
What Other Side Effects Does ROSUVASTATIN\ROSUVASTATIN Cause?
Dyspnoea (79)
Asthma (77)
Pneumonia (52)
Acute kidney injury (50)
Wheezing (50)
Myalgia (48)
Drug hypersensitivity (46)
Fatigue (44)
Pain (44)
Rhabdomyolysis (43)
What Other Drugs Cause Interstitial lung disease?
METHOTREXATE (3,049)
RITUXIMAB (2,458)
PEMBROLIZUMAB (2,113)
PREDNISONE (1,850)
CYCLOPHOSPHAMIDE (1,725)
NIVOLUMAB (1,538)
AMIODARONE (1,421)
DOXORUBICIN (1,352)
ETANERCEPT (1,267)
ADALIMUMAB (1,250)
Which ROSUVASTATIN\ROSUVASTATIN Alternatives Have Lower Interstitial lung disease Risk?
ROSUVASTATIN\ROSUVASTATIN vs ROTIGOTINE
ROSUVASTATIN\ROSUVASTATIN vs ROXADUSTAT
ROSUVASTATIN\ROSUVASTATIN vs ROXICODONE
ROSUVASTATIN\ROSUVASTATIN vs ROXITHROMYCIN
ROSUVASTATIN\ROSUVASTATIN vs ROZANOLIXIZUMAB